Amgen 2004 Annual Report Download - page 20

Download and view the complete annual report

Please find page 20 of the 2004 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 38

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38

1
980
A sma
ll g
roup
of vent
u
re
c
a
p
italists,
l
e
db
y Bi
ll
Bowes,
esta
bl
is
h
es
A
M
G
en
(
Applied
(
M
o
l
ecu
l
ar
G
enetics Inc.)
,
h
ead
q
uartered in
T
h
ousan
d
Oa
k
s,
California,
on A
p
ril
8
G
eor
g
e B.
R
at
hm
a
nn
name
d
presi
d
ent
an
d
chief
exec
u
tive offi cer
25
y
ears of visionar
y
science
and
p
owerful medicine
1
98
3
F
u
-K
u
en Lin
cl
ones t
h
e
h
uman
e
ryt
h
ropoietin
g
ene
a
nd subse
q
uently
p
ro
d
uces t
h
e
fi
rst
h
uman eryt
h
ropoietin
p
roduct, later
p
atente
d
an
d
name
d
E
P
OG
E
N
®
(
Ep
oetin alfa
)
Initia
l
pu
bl
ic
o
ffering of
2
,
350
,
00
0
s
h
ares
resu
l
ts in near
l
y
$
40
milli
o
n
raise
d;
NASDA
Q
t
ic
k
er sym
b
o
l
:
A
M
GN
1
98
5
A
team led b
y
L
arry Souza c
l
ones
g
ranu
l
ocyte
colony-stimulating
f
actor
(
G
-
CSF
)
,
l
ater patente
d
an
d
name
d
N
E
U
P
OG
E
N
®
(
F
i
lg
rastim
)
1
9
8
1
A
mgen r
a
i
ses
$
19.
4
mi
ll
ion
i
n venture
ca
p
ital
—
e
noug
h
to
h
ire a team
o
f
sc
i
e
n
t
i
sts
1
9
8
2
Gor
d
on M.
Bin
d
er joins
A
m
g
en as c
h
ie
f
fi
n
a
nc
i
a
l
o
ffi
ce
r
1
9
8
4
K
irin Brewer
y
C
ompany an
d
A
m
g
en
f
orm a
joint venture,
K
irin-
A
mgen Inc.,
f
or t
h
e wor
ld
wi
d
e
co
mm
e
r
c
i
a
liz
at
i
o
n
of
eryt
h
ropoietin
Amgen 2004 Annual Report
t
p
a
g
e
18